Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called "superbugs" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs).
Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
So, the way it actually works is, I can describe what would happen, let's say a patient walks in the door, let's say you have a hospital, patient might be coming in for foot surgery, something very simple. Before the patient is taken to the room, you know, right when they come into the door, they'l...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login